Search hospitals > Iowa > Davenport
Iowa Cancer Specialists
Claim this profileDavenport, Iowa 52807
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast cancer
Conducts research for Lung Carcinoma
33 reported clinical trials
1 medical researcher
Summary
Iowa Cancer Specialists is a medical facility located in Davenport, Iowa. This center is recognized for care of Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast cancer, Lung Carcinoma and other specialties. Iowa Cancer Specialists is involved with conducting 33 clinical trials across 38 conditions. There are 1 research doctors associated with this hospital, such as David M. Spector.Area of expertise
1Breast Cancer
Global LeaderHER2 positive
ER positive
HER2 negative
2Lung Cancer
Global LeaderStage III
Stage II
Stage I
Top PIs
Clinical Trials running at Iowa Cancer Specialists
Lung Cancer
Non-Small Cell Lung Cancer
ALK Gene Rearrangement
Cancer
Squamous Cell Carcinoma
Anaplastic Large Cell Lymphoma
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Iowa Cancer Specialists?
Iowa Cancer Specialists is a medical facility located in Davenport, Iowa. This center is recognized for care of Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Breast cancer, Lung Carcinoma and other specialties. Iowa Cancer Specialists is involved with conducting 33 clinical trials across 38 conditions. There are 1 research doctors associated with this hospital, such as David M. Spector.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.